Matthew Fenske's Contact Details

Matthew Fenske's Company Details

Clinvest

Springfield, MO, US • 20 - 49 Employees
Market Research

We are a research organization dedicated to the advancement of medicine and health management through clinical research. Our vision is to explore concepts sparked by information gathered in the clinic setting. A Clinical Research SiteWe are passionate about new concepts for disease control and prevention. We work with some of the nation's top headache specialists, as well as other specialty physicians in the Springfield, Missouri area. We conduct FDA Phase II-IV research at our centrally located, state of the art facility. The majority of the research studies conducted are multi-center nation or world-wide studies involving hundreds to thousands of participants. Our dedicated team of Research Professionals are committed to excellence, making us one of the leaders in the field of Clinical Research. Clinvest Clinical Research has conducted more than 400 clinical trials sponsored by leading global pharmaceutical companies in a number of research areas including headache, hypertension, diabetes, osteoarthritis, GI disorders, Alzheimer's disease, fibromyalgia, herpes simplex, asthma, low back pain, inflammatory bio-markers, and hyperlipidemia.Clinvest also serves as A SPECIALTY CRO COMPRISED OF DEDICATED, KNOWLEDGEABLE STAFF, AND A NETWORK (600+) OF EXCEPTIONAL CLINICAL INVESTIGATORS WHO ARE ACTIVELY INVOLVED IN PATIENT CARE.Dedicated to technology, customer service, study design, regulatory requirements, and data analysis. Together we can help navigate your product to produce the best outcomes and pave the way for success.Our research is based on your vision. You will be working with the same team of Clinvest professionals from the beginning to the end of your study ensuring your needs are properly addressed.Adequate research and accurate data are the key factors in product advancement. By helping you throughout the entire clinical trial process, we can avoid potential pitfalls which hinder many studies.